<p>Orchid Pharma Limited will hold a board meeting on Tuesday, October 20, 2026, to consider and evaluate options for raising funds through the issue of equity shares or other eligible securities, including convertible debentures, or a combination of non-convertible debentures and warrants, potentially via qualified institutions placement, preferential issue, private placement, public issue, or debt securities, subject to required statutory and regulatory approvals.</p>